Le Lézard
Classified in: Health
Subject: PDT

ENCORE Introduces Innovative Beverage Mixes Featuring Science-Backed Cognizin® and IMMUSEtm for Cognitive and Beauty Support


Kyowa Hakko's Cognizin® Citicoline, and postbiotic, IMMUSEtm, infuse their cutting-edge components in the new product line.

NEW YORK , April 18, 2024 /PRNewswire-PRWeb/ -- Kyowa Hakko U.S.A., Inc. announces the inclusion of its science-backed branded ingredients Cognizin® and IMMUSEtm in two groundbreaking beverage mixes designed to elevate the daily nutrition regimen of health-conscious consumers. These innovative products from ENCORE harness the power of high-quality ingredients to bring cognitive and beauty benefits in delicious, easy-to-consume formats.

Introducing Cognizin®: ENCORE Focus MCT Creamer
Encore's Focus MCT creamer is a crafted formulation that aims to enhance mental focus and fuel energy through its powerhouse blend of MCT oil, Cognizin®, Fibersol®, and DE111 Probiotic®. With three great-tasting flavors ?Vanilla, Turmeric, and Original? Focus MCT creamer is set to become a staple addition for anyone seeking to support their cognitive function throughout the day.

Unveiling IMMUSEtm: ENCORE Shine Collagen Mix
Encore's new Shine Collagen Mix features an exciting combination of ingredients supporting the body's natural wellness and beauty. Featuring IMMUSEtm to strengthen natural immunity, VERISOL®, and Fibersol®, this product supports skin beauty from within, promoting a healthy, radiant complexion. Delight in the three flavors ?Matcha, Rooibos, and Original?and effortlessly integrate this collagen mix into your daily beauty routine.

"This exciting partnership with ENCORE perfectly aligns with our commitment to delivering specialty materials that contribute to good health," Karen Todd, RD, CSCS, EP-C, CISSN, and Vice President of Global Brand Marketing, Kyowa Hakko USA, Inc. said. Todd added, "The new products featuring Cognizin® and IMMUSEtm provide a 'better for you beverage mix,' ensuring the delivery of nutrients consumers want to incorporate in their daily health routines."

ENCORE's new offerings exemplify its commitment to delivering products that taste great and serve a functional purpose for people's well-being. "We are thrilled to present our customers with these unique beverage mixes that include cutting-edge nutritional science ingredients like Cognizin® and IMMUSEtm, and we're proud to make them accessible to our consumers in formulas they can enjoy daily," said KAV Encore CEO, Tak Lam.

Both product lines are now available on ENCORE's website, encouraging individuals to discover the fusion of flavor and function and fostering a lifestyle that prioritizes health without compromising taste. For more information about Encore's new products, please visit cheersencore.com.

About Kyowa Hakko USA:
Kyowa Hakko USA is the North & South American office of Kyowa Hakko Bio Co. Ltd., an international health ingredients manufacturer and world leader in the development, manufacturing, and marketing of pharmaceuticals, nutraceuticals, and food & beverage products. Kyowa is the maker of branded ingredients, including Cognizin®, IMMUSEtm LC-Plasma, Eyemusetm Lacticaseibacillus paracasei KW3110, Citicoline, Pantesin® Pantethine, Setria® Glutathione, as well as L-Alanyl-L-Glutamine. For more information, visit kyowa-usa.com

About ENCORE:
Encore is a pioneering company specializing in the development of supplements and beverage mixes that promote a healthier and more vibrant lifestyle. With a commitment to quality, Cheers Encore offers a range of products that not only provide essential nutrients but also enhance the consumer experience with exceptional taste.

Media Contacts:
Giselle Chollett
[email protected]
917.386.7116.

Media Contact

Maria Stanieich, Kyowa Hakko USA, 15514829968, [email protected], kyowa-usa.com

SOURCE Kyowa Hakko USA


These press releases may also interest you

at 18:33
BioVaxys Technology Corp. (FRA: 5LB) (the "Company") is pleased to announce that it has closed the first tranche (the "First Tranche") of its previously announced non-brokered private placement (the "Private Placement") with the issuance of...

at 18:29
Filament Health Corp. (Cboe CA: FH) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company, today announced that Chris Wagner has stepped down from his position as Director on the Company's board of directors...

at 18:20
Starting this week, National Alliance for Hispanic Health, Ibero American Action League Inc., University of Rochester Medical Center, and Trillium Health in Rochester, NY will host the All of Us Journey, a traveling educational exhibit that brings...

at 18:00
BetterLife Pharma Inc. ("BetterLife" or the "Company") , an emerging biotech company focused on the development and commercialization of non-hallucinogenic LSD-based therapeutics for mental disorders, today announced that the Company intends to...

at 17:48
Andlauer Healthcare Group Inc. ("AHG" or the "Company") announced today the results of voting at its virtual annual meeting of shareholders held on May 3, 2024 (the "Meeting"). All of the nominees listed in the management information circular...

at 17:37
Starting this week, Little Manilla Rising, University of California, San Francisco, and Community Medical Centers in Stockton, CA will host the All of Us Journey, a traveling educational exhibit that brings the National Institutes of Health's All of...



News published on and distributed by: